Schiller J J - OmicsDI

Show results for

Unknown (1720)
Proteomics (31)
Metabolomics (12)
Models (3)
Transcriptomics (1)

Organisms

Homo sapiens (14)
Mus musculus (10)
Danio rerio (2)
Archaea (1)
Aspergillus fumigatus (1)
Caenorhabditis elegans (1)
Chlamydomonas reinhardtii CC3269 (1)
Haloferax volcanii (1)
Mycobacterium tuberculosis (1)
Staphylococcus aureus (1)
Yarrowia lipolytica (1)

Repository

pride (29)
MetaboLights (12)
BioModels (3)
PAXDB (2)
biostudies-arrayexpress (1)

Tissue

Lung (4)
Blood plasma (3)
Blood (2)
Brain (2)
Cell culture (2)
Kidney (2)
Macrophage (2)
Aorta (1)
Blood cell (1)
Blood serum (1)
Conidium (1)
Epithelial cell (1)
Femur (1)
Fibroblast (1)
Liver (1)
Photosynthetic cell (1)
Seminal plasma (1)
Skin (1)
Spinal cord (1)
T cell (1)
Tibia (1)
Whole body (1)

Disease

Disease free (2)
Atherosclerosis (1)
Extrapulmonary tuberculosis (1)
Idiopathic pulmonary fibrosis (1)
Lymph node tuberculosis (1)
Male infertility (1)
Pulmonary tuberculosis (1)

Technology Type

Mass Spectrometry (29)
Shotgun proteomics (23)
Mass spectrometry (10)
Bottom-up proteomics (5)
Affinity purification coupled with mass spectrometry proteomics (2)
Mass spectrometry assay (1)
NMR spectroscopy (1)
Data-dependent acquisition (1)
Data-independent acquisition (1)
Gel-based experiment (1)
HDMSE (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (3)
Gas Chromatography MS - positive (2)
Liquid Chromatography MS - positive - hilic (2)
Autoflex speed smartbeam (1)
Gas Chromatography MS - (1)
Gas Chromatography MS - Positive (GC-MS (Positive)) (1)
ISQ LT (Thermo) (1)
Liquid Chromatography MS - - reverse phase (1)
Liquid Chromatography MS - alternating - hilic (1)
Liquid Chromatography MS - alternating - reverse phase (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - negative - reverse phase (1)
MS Imaging - (1)
MaXis (Bruker) (1)
Nuclear Magnetic Resonance (NMR) - (1)

Publication Date

2020 (8)
2023 (7)
2024 (5)
2026 (5)
2022 (4)
2021 (4)
2019 (4)
2017 (3)
2016 (3)
2018 (2)
2013 (1)
2025 (1)

UNIPROT ID/AC

10090.ENSMUSP00000032399 (2)
10090.ENSMUSP00000097919 (2)
1433B_MOUSE (2)
1433E_MOUSE (2)
O14744 (1)
O14980 (1)
O95149 (1)
P08621 (1)
P09012 (1)
P09234 (1)
P14678 (1)
P43487 (1)
P52292 (1)
P52297 (1)
P52298 (1)
P60510 (1)
P62304 (1)
P62306 (1)
P62308 (1)
P62314 (1)
P62316 (1)
P62318 (1)
P62826 (1)
Q09161 (1)
Q14974 (1)
Q16637 (1)
Q8IZH2 (1)
Q92973 (1)
Q96RS0 (1)
Q9H814 (1)

CHEBI ID

CHEBI:17234 (5)
CHEBI:33942 (5)
CHEBI:10642 (3)
CHEBI:15428 (3)
CHEBI:16457 (3)
CHEBI:16467 (3)
CHEBI:17750 (3)
CHEBI:17822 (3)
CHEBI:18222 (3)
CHEBI:25017 (3)
CHEBI:26271 (3)
CHEBI:26986 (3)
CHEBI:27266 (3)
CHEBI:28044 (3)
CHEBI:30769 (3)
CHEBI:36751 (3)
CHEBI:15891 (2)
CHEBI:16010 (2)
CHEBI:16199 (2)
CHEBI:16335 (2)
CHEBI:16414 (2)
CHEBI:16449 (2)
CHEBI:16708 (2)
CHEBI:16919 (2)
CHEBI:15422 (1)
CHEBI:37565 (1)
CHEBI:43474 (1)
CHEBI:58189 (1)
CHEBI:74035 (1)
CHEBI:84596 (1)

Metabolite Name

Adenine (2)
Adenosine (2)
Alanine (2)
Asparagine (2)
Choline (2)
Citric acid (2)
Ectoine (2)
Glucose (2)
Glutamine (2)
Glycine (2)
Glycine betaine (2)
Hypoxanthine (2)
Inosine (2)
L-arginine (2)
L-phenylalanine (2)
L-proline (2)
L-proline betaine (2)
L-tyrosine (2)
L-valine (2)
Leucine (2)
Methionine (2)
N(omega),N(omega)-dimethyl-L-arginine (2)
Phenylalanine (2)
S,S-dimethyl-beta-propiothetin (2)
Tryptophan (2)
Tyrosine (2)
Valine (2)
Xanthine (2)
(16:0)1-palmitoyl-sn-glycero-3-phosphocholine (1)
(i) (Di-)Galactosylglycerol (1)

IsPrivate

False (3)

Model Flag

Non Kinetic (2)

Modelling Approach

Petri net (1)

Modification

-17.026549 (1)
-18.010565 (1)
15.994915 (1)
42.010565 (1)
4x(2)H labeled dimethylated residue (1)
57.021464 (1)
79.966331 (1)

Study type

Transcription profiling by array (1)

Release Date

2022 (195)
2025 (192)
2023 (186)
2024 (163)
2021 (159)
2020 (114)
2018 (92)
2019 (88)
2016 (87)
2015 (80)
2017 (79)
2014 (58)
2026 (41)
2012 (39)
2013 (34)
2011 (34)
2010 (24)
2009 (20)
2008 (8)
2007 (8)
2005 (6)
2006 (4)
2004 (4)
2002 (3)
2003 (1)
2000 (1)
1998 (1)

Lab affiliation

Helmholtz Zentrum München, Institute of Lung Biology and Disease, Group Systems Medicine of Chronic Lung Disease, Member of the German Center for Lung Research (DZL), Munich, Germany (2)
Institute of Lung Biology and Disease and Comprehensive Pneumology Center, Helmholtz Zentrum München, Member of the German Center for Lung Research (DZL), Munich, German (2)
Max Planck Institute for the Science of Light & Max-Planck-Zentrum für Physik und Medizin Division Biological Optomechanics Staudtstr. 2 91058 Erlangen Germany (2)
1) Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany 2) CECAD, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany (1)
1) Department of Molecular and Applied Microbiology, Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute, Jena, Germany 2) Department of Microbiology and Molecular Biology, Friedrich Schiller University, Jena, Germany (1)
Australian Proteome Analysis Facility, Macquarie University, Sydney NSW 2109, Australia (1)
CECAD-Cluster of Excellence, University of Cologne, Joseph-Stelzmann-Str. 26, D-50931, Cologne, Germany; Department II of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Kerpener Str. 62, D-50937, Cologne, Germany; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Robert-Koch-Str. 21, D-50931, Cologne, Germany (1)
Chair of Proteomics and Bioanalytics, TU Muenchen (1)
Department of Biochemistry (286) Radboud University Medical Centre Radboud Institute for Molecular Life Sciences P.O. Box 9101 NL-6500 HB Nijmegen The Netherlands (1)
Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA (1)
Department of Proteomics and Signal Transduction, Max-Planck Institute of Biochemistry, Martinsried, Germany (1)
Fraunhofer Institute for Cell Therapy and Immunology IZI, Department Preclinical Development and Validation, Proteomics Unit, Leipzig, Germany (1)
General Botany, Matthias-Schleiden-Institut, Friedrich-Schiller University Jena Am Planetarium 1, 07743 Jena, Germany (1)
Helmholtz Zentrum München, Institute of Lung Biology and Disease, Group Regenerative Biology and Medicine, Munich, Germany, Member of the German Centre for Lung Research (DZL) (1)
Helmholtz Zentrum München, Institute of Lung Biology and Disease, Member of the German Center for Lung Research (DZL), Munich, Germany (1)
Institut für Biochemie und Biophysik Friedrich-Schiller-Universität Hans-Knöll-Str. 2, D-07745 Jena (1)
Institute of Biochemistry II, University Hospital, Goethe University, Frankfurt am Main, Germany. (1)
Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Am Klinikum 1, 07747 Jena, Germany Center for Rare Diseases, University Hospital Jena, Friedrich Schiller University, Am Klinikum1, 07747 Jena, Germany (1)
Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Am Klinikum1, 07747 Jena, Germany (1)
LMU Muenchen (1)
Medizinische Universität Wien Center for Pathophysiology, Infectiology and Immunology Lazarettgasse 19 1090 Vienna, Austria (1)
Pysiological Genomics, LMU Muenchen, Germany (1)
Research Unit for Precision Regenerative Medicine, Helmholtz Munich, Comprehensive Pneumology Center, Member of the German Center for Lung Research (DZL), Munich, Germany Institute of Experimental Pneumology, LMU University Hospital, Ludwig-Maximilians University, Munich, Germany (1)
The Scripps Research Institute (1)
University of Pennsylvania, Department of Biology (1)
university of Edinburgh (1)

Previous page
1 / 177
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 177
Next page

Sort by:

Relevance

Page size

Miz-1 regulates translation of Trp53 via ribosomal protein L22 in cells undergoing V(D)J recombination.

Not available

S-EPMC4273400 | biostudies-literature

An atlas of the aging lung mapped by single cell transcriptomics and deep tissue proteomics

Aging promotes lung function decline and susceptibility to chronic lung diseases, which are the third leading cause of death worldwide. We used single cell transcriptomics and mass spectrometry to quantify changes in cellular activity states of 30 cell types and the tissue proteome from lungs of you...

ORGANISM(S): Mus musculus (Mouse)

2019-01-21 | PXD012307 | Pride

Dual functions of Nbs1 in the repair of DNA breaks and proliferation ensure proper V(D)J recombination and T-cell development.

Not available

S-EPMC2976431 | biostudies-literature

A Randomized Comparison of Delivered Energy in Cardioversion of Atrial Fibrillation: Biphasic Truncated Exponential Versus Pulsed Biphasic Waveforms.

Not available

S-EPMC8235401 | biostudies-literature

Pam17 and Tim44 act sequentially in protein import into the mitochondrial matrix.

Not available

S-EPMC3353651 | biostudies-literature

Peptide Szeto‑Schiller 31 ameliorates doxorubicin‑induced cardiotoxicity by inhibiting the activation of the p38 MAPK signaling pathway.

Not available

S-EPMC7914074 | biostudies-literature

Wet-Spun Chitosan-Sodium Caseinate Fibers for Biomedicine: From Spinning Process to Physical Properties.

Not available

S-EPMC10855522 | biostudies-literature

A proteomics workflow reveals predictive autoantigens in idiopathic pulmonary fibrosis (cohort 1)

Rationale: The diagnosis of idiopathic pulmonary fibrosis (IPF) requires exclusion of an underlying autoimmune disease, as present in interstitial lung diseases associated with connective tissue diseases (CTD-ILD). The prevalence of autoantibodies in IPF patients is currently unknown. Objectives: An...

ORGANISM(S): Homo sapiens (Human)

2021-02-22 | PXD024113 | Pride

Ipf Ctd-ild Clinical proteomics Autoantibodies Autoimmunity Lung fibrosis

Gut microbiome dysbiosis drives metabolic dysfunction in Familial dysautonomia

Familial dysautonomia (FD) is a rare genetic neurologic disorder caused by impaired neuronal development and progressive degeneration of both the peripheral and central nervous systems. FD is monogenic, with >99.4% of patients sharing an identical point mutation in the elongator acetyltransferase co...

2022-12-06 | MTBLS5138 | MetaboLights

A systematic review and meta-analysis of percutaneous coronary intervention compared to coronary artery bypass grafting in non-ST-elevation acute coronary syndrome.

Not available

S-EPMC8948200 | biostudies-literature

Previous page
1 / 177
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 177
Next page

Sort by:

Relevance

Page size

1767 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

CHEBI ID

Metabolite Name

IsPrivate

Model Flag

Modelling Approach

Modification

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets